United States · FDA National Drug Code directory
Cholestyramine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-319_c41529f1-16d2-4ca3-91eb-f809571f5ae3
- Product NDC
- 33342-319
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cholestyramine
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241121
- Source listing expiry
- 20261231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/5.7g
These values do not establish equivalence or a dose recommendation.
Packages
- 60 POUCH in 1 CARTON (33342-319-70) / 5.7 g in 1 POUCH (33342-319-01) · 33342-319-70
- 42 POUCH in 1 CARTON (33342-319-72) / 5.7 g in 1 POUCH (33342-319-01) · 33342-319-72
- 239.4 g in 1 JAR (33342-319-83) · 33342-319-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →